scPharmaceuticals Inc. (SCPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
2400 District Avenue
Burlington, MA 01803
United States of America (the)
Phone
617 517 0730
Sector
Healthcare
Industry
Biotechnology
Employees
162
First IPO Date
November 17, 2017
| Name | Title | Pay | Year Born |
| John H. Tucker | President, Chief Executive Officer, Principal Executive Officer & Director | 1.05M | 1963 |
| Rachael Nokes | Chief Financial Officer | 632,154 | 1976 |
| John Mohr | Senior Vice President of Clinical Development & Medical Affairs | 0 | N/A |
| Katherine Taudvin | Vice President of Corporate Affairs & Human Resources | 0 | N/A |
| Michael D. Hassman | Senior Vice President of Technical Operations | 0 | N/A |
| Steve Parsons | Senior Vice President of Commercial | 0 | N/A |
scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encompasses scCeftriaxone, an antibiotic aimed at treating infections caused by both gram-positive and gram-negative bacteria, as well as the scCarbapenem program, another antibiotic designed for gram-negative bacterial infections. Additionally, scPharmaceuticals has entered into a collaboration agreement with West Pharmaceutical Services, Inc. for the advancement of a single-use SmartDose device. Founded in 2013, the company's main operations are based in Burlington, Massachusetts.